New opportunities for the management of cancer-related bone complications

Clin Adv Hematol Oncol. 2009 May;7(5 Suppl 11):1-30; quiz 31.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Diseases, Metabolic / chemically induced
  • Bone Diseases, Metabolic / prevention & control*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / prevention & control
  • Bone Neoplasms / secondary*
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Male
  • Osteogenesis / physiology

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents